Samsca FDA Approval History
FDA Approved: Yes (First approved May 19, 2009)
Brand name: Samsca
Generic name: tolvaptan
Dosage form: Tablets
Company: Otsuka Pharmaceutical Development & Commercialization, Inc.
Treatment for: Hyponatremia
Samsca (tolvaptan) is an oral selective vasopressin antagonist for the treatment of patients with clinically significant hypervolemic and euvolemic hyponatremia.
Development timeline for Samsca
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.